T he ischemic penumbra was defined by Astrup et al 1 as brain tissue perfused at a level within the thresholds of functional impairment and morphological integrity, which has the capacity to recover if perfusion is improved. Because tolerance of tissue to ischemic damage is dependent on residual flow and duration of flow disturbance, 2 the ischemic penumbra characterizes a transient condition: it exists for a short period even in the center of ischemia, and may extend to increasing time periods in the more or less hypoperfused surrounding tissue. The concept of the ischemic penumbra has been developed from animal experiments in which regional flow measurements could be clearly related to the functional/morphological state of the tissue. Its transfer to the clinical situation requires the definition of 3 critical values that usually cannot be assessed in the acute stage of ischemic stroke: (1) quantitation of flow in the core and the periphery of the territory with impaired blood supply; (2) state of the various tissue compartments within the affected area with respect to irreversibly damaged or preserved morphology; and (3) the time period the respective tissue compartments have been exposed to more or less severe hypoperfusion. As all clinically available methods at best yield only momentary assessments of brain perfusion and tissue condition at several hours after the vascular attack, the development of these changes over time remains obscure, and predictions on the fate of the tissue from the measurable variables must be vague. Therefore, the definition of penumbra tissue in the clinical setting is limited to accurate assessments of perfusion in the core, the periphery and the surrounding of the territory with impaired blood supply, and the detection of irreversibly damaged tissue at the time of investigation.
Positron emission tomography (PET) was leading in the clinical assessment of the penumbra: multitracer studies defined the penumbra as tissue with reduced cerebral blood flow (CBF) but preserved oxygen consumption (CMRO 2 ) and raised oxygen extraction fraction (OEF). 3, 4 For the definition of irreversible tissue damage at the time of investigation (usually several hours after the ischemic event), the cerebral metabolic rate for oxygen (CMRO 2 ) is the most reliable parameter with Ϸ65 mol · 100 g Ϫ1 · min Ϫ1 as the threshold.
In the studies relating early CBF and CMRO 2 measurements to infarcts determined on late CT, a flow threshold of 12 mL · 100 g Ϫ1 · min Ϫ1 was described, which also predicted irreversible damage. These determinations of flow and energy metabolism, however, require complex logistics for investigations of acute stroke patients and necessitate arterial blood sampling, and therefore are difficult to perform in the clinical setting and prohibited when invasive therapies, eg, thrombolysis, are planned. Therefore, tracers are required that indicate tissue integrity or hypoxia, and in combination with semiquantitative determinations of perfusion can outline noninvasively the extent of penumbra tissue. The central benzodiazepine receptor ligand flumazenil (FMZ) labeled with 11-C is a marker of integrity and detects neuronal damage in the cortex in the first hours after ischemic stroke. The extent of decreased accumulations of this tracer in the cortex correlates significantly with the extent of tissue with CMRO 2 reduced below the critical threshold and identifies irreversible damage even in areas with increased OEF. Tissue compartments with FMZ binding below a critical threshold cannot benefit from reperfusion-a finding that also supports the ability of the tracer to identify developing infarcts. 4 In a study in which the final infarcts were analyzed with respect to flow values and FMZ uptake in the first hours after stroke, probability thresholds of FMZ binding and blood flow could be calculated, which predicted the final state of the tissue and defined the range of the penumbra. 5 As the 95% prediction limit for infarction the FMZ uptake of 3.4 times the average of white matter was found, as the flow range for the penumbra 4.8 to 14.1 mol · 100 g Ϫ1 · min Ϫ1 were obtained. Due to the low concentration of benzodiazepine receptors in white matter and basal ganglia, these values apply only to the cortex but still permit a reliable measure of irreversibly damaged and potentially salvageable portions of an ischemically compromised area. These values are comparable to those determined in invasive studies 3 if the errors inherent in determinations based on low count rates are taken into consideration.
As a tracer of hypoxic viable tissue, 18-Ffluoromisonidazole (FMISO) could also be used to detect ischemic penumbra. Areas with increased FMISO uptake were detected 6.25 to 42.5 hours after stroke. It is maximal in the initial hours after onset, declines with time, and is absent after several days. The areas were usually distributed over the periphery of the infarct identified on the coregistered late CT, but extended into normal tissue adjacent to the infarct in a few cases. 6 These findings suggest that FMISO binding is increased in tissue at risk and mirrors the temporal and spatial distribution of penumbra. However, these results need direct calibration by conventional PET measurements. Since reli-able detection of FMISO uptake is delayed (Ͼ2 hours between tracer injection and imaging), the value of this tracer is limited for therapeutic decisions in the acute phase of ischemic stroke.
As long as other imaging modalities do not yield reliable detection of irreversible tissue damage-even diffusionweighted MRI might be misleading in some cases 7 -and do not furnish quantitative values of blood flow for the upper limit of penumbra, PET procedures must be considered still the gold standard for the recognition of penumbra. However, PET is limited by the required expensive equipment and the complex logistics involving a multidisciplinary team. Therefore, time has come to calibrate simpler and widely applicable functional imaging procedures-especially diffusion-and perfusionweighted MRI-on PET in order to make these modalities a reliable tool in the study of acute ischemic stroke.
